
VolitionRx Limited VNRX
$ 0.2
-2.41%
Quarterly report 2025-Q3
added 11-13-2025
VolitionRx Limited Operating Cycle 2011-2026 | VNRX
Annual Operating Cycle VolitionRx Limited
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 52.3 | 74.2 | 50.7 | 39.8 | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 74.2 | 39.8 | 54.2 |
Quarterly Operating Cycle VolitionRx Limited
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 36.3 | 42.3 | 55.3 | - | 46 | 34.5 | 100 | - | 63.8 | 66.5 | 58.2 | - | 19.5 | 92.8 | 33.9 | - | 63.4 | 55.4 | 38.2 | - | 1.13 K | 125 | 597 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 20.9 | 107 | 45.6 | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.13 K | 19.5 | 135 |
Operating Cycle of other stocks in the Diagnostics research industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Anixa Biosciences
ANIX
|
275 | $ 2.89 | -2.36 % | $ 93.8 K | ||
|
Centogene N.V.
CNTG
|
170 | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
161 | $ 118.67 | 0.46 % | $ 36.1 B | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
Castle Biosciences
CSTL
|
97.9 | $ 27.81 | -0.64 % | $ 772 M | ||
|
Charles River Laboratories International
CRL
|
65 | $ 177.9 | -0.41 % | $ 8.82 B | ||
|
Aspira Women's Health
AWH
|
73.8 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
489 | - | -61.36 % | $ 2.46 M | ||
|
Global Cord Blood Corporation
CO
|
202 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
11.8 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
185 | - | 0.12 % | $ 80.1 M | ||
|
Fulgent Genetics
FLGT
|
77.4 | $ 14.03 | -1.23 % | $ 424 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.22 K | - | - | $ 10.7 B | ||
|
Biodesix
BDSX
|
41.7 | $ 15.96 | 1.3 % | $ 2.07 B | ||
|
Biocept
BIOC
|
134 | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
329 | $ 1.1 | -3.49 % | $ 1.4 M | ||
|
Quest Diagnostics Incorporated
DGX
|
54.2 | $ 208.55 | -0.82 % | $ 23.1 B | ||
|
Danaher Corporation
DHR
|
143 | $ 202.93 | -1.44 % | $ 145 B | ||
|
Exact Sciences Corporation
EXAS
|
91.7 | $ 103.39 | 0.04 % | $ 19.5 B | ||
|
Bioventus
BVS
|
267 | $ 8.85 | 0.91 % | $ 554 M | ||
|
DarioHealth Corp.
DRIO
|
251 | $ 10.5 | -2.33 % | $ 298 M | ||
|
DexCom
DXCM
|
202 | $ 72.97 | -1.1 % | $ 28.5 B | ||
|
QIAGEN N.V.
QGEN
|
172 | - | - | $ 10.6 B | ||
|
Burning Rock Biotech Limited
BNR
|
275 | $ 24.2 | -3.82 % | $ 254 M | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 18.66 | -0.45 % | $ 994 M | ||
|
Chembio Diagnostics
CEMI
|
164 | - | 0.22 % | $ 16.8 M | ||
|
ICON Public Limited Company
ICLR
|
68.5 | $ 108.73 | 0.42 % | $ 8.97 B | ||
|
IDEXX Laboratories
IDXX
|
128 | $ 635.4 | -0.2 % | $ 51.1 B | ||
|
Illumina
ILMN
|
198 | $ 130.82 | -1.55 % | $ 20.8 B | ||
|
Guardant Health
GH
|
128 | $ 93.48 | 1.35 % | $ 11.7 B | ||
|
Laboratory Corporation of America Holdings
LH
|
71.8 | $ 283.3 | -1.03 % | $ 23.6 B | ||
|
IQVIA Holdings
IQV
|
73.9 | $ 174.31 | 0.02 % | $ 30 B | ||
|
Lantheus Holdings
LNTH
|
121 | $ 78.0 | 2.23 % | $ 5.26 B | ||
|
Co-Diagnostics
CODX
|
405 | - | - | $ 79.8 M | ||
|
Mettler-Toledo International
MTD
|
66.4 | $ 1 317.07 | -0.45 % | $ 27.1 B | ||
|
DermTech
DMTK
|
114 | - | -11.32 % | $ 2.94 M | ||
|
Myriad Genetics
MYGN
|
95.1 | $ 5.26 | 4.99 % | $ 487 M | ||
|
NeoGenomics
NEO
|
102 | $ 9.5 | - | $ 1.22 B | ||
|
Enzo Biochem
ENZ
|
206 | - | -8.98 % | $ 14.8 K | ||
|
Natera
NTRA
|
81.5 | $ 208.69 | 4.26 % | $ 20.5 B | ||
|
Pacific Biosciences of California
PACB
|
244 | $ 1.54 | -4.94 % | $ 462 M | ||
|
Neogen Corporation
NEOG
|
213 | $ 11.01 | -1.3 % | $ 2.39 B | ||
|
Precipio
PRPO
|
49.8 | $ 24.5 | -0.73 % | $ 31.8 M | ||
|
Heska Corporation
HSKA
|
177 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
216 | - | -20.0 % | $ 1.06 M |